MicroRNA-144 affects radiotherapy sensitivity by promoting proliferation, migration and invasion of breast cancer cells
- PMID: 26252024
- DOI: 10.3892/or.2015.4173
MicroRNA-144 affects radiotherapy sensitivity by promoting proliferation, migration and invasion of breast cancer cells
Abstract
Radiotherapy resistance remains a major obstacle for patients with breast cancer. miRNAs are important regulators in many biological processes including proliferation, apoptosis, invasion and metastasis and response to treatment in different types of tumors. Here, we describe the role of miRNA-144 in the regulation of radiotherapy sensitivity, migration and invasion of breast cancer cells. The cell survival rate of breast cancer cells was measured by WST-1 assay after irradiation. The caspase-3/-7 activity and apoptotic proteins were analyzed by Caspase-Glo3/7 assay and western blot analysis, respectively. The migration and invasion of breast cancer cells were evaluated by BD Transwell migration and Matrigel invasion assays. The EMT markers were detected by western blot analysis. We found that overexpression of miR-144 increased the proliferation rate of MDA-MB-231 cells without radiation. Both MDA-MB‑231 and SKBR3 cells exhibited significantly increased radiation resistance after overexpression of miR-144. Meanwhile, the migration and invasion of both MDA-MB-231 and SKBR3 cells were changed by altered miR-144 expression. In addition, the overexpression of miR-144 inhibited E-cadherin expression and promoted Snail expression. miR-144 activated AKT by downregulation of PTEN in breast cancer cells. Our results strongly suggest that miR-144 acts as an important regulator of tumorigenesis and tumor progression of breast cancer. These results indicate that miR-144 might serve as a potential molecular target for breast cancer treatment.
Similar articles
-
MicroRNA-498 promotes proliferation, migration, and invasion of prostate cancer cells and decreases radiation sensitivity by targeting PTEN.Kaohsiung J Med Sci. 2019 Nov;35(11):659-671. doi: 10.1002/kjm2.12108. Epub 2019 Jul 22. Kaohsiung J Med Sci. 2019. PMID: 31332950 Free PMC article.
-
miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2.Exp Biol Med (Maywood). 2018 Mar;243(5):473-480. doi: 10.1177/1535370218754848. Epub 2018 Jan 25. Exp Biol Med (Maywood). 2018. PMID: 29368542 Free PMC article.
-
MicroRNA-31 controls G protein alpha-13 (GNA13) expression and cell invasion in breast cancer cells.Mol Cancer. 2015 Mar 26;14:67. doi: 10.1186/s12943-015-0337-x. Mol Cancer. 2015. PMID: 25889182 Free PMC article.
-
miR-21, An Oncogenic Target miRNA for Cancer Therapy: Molecular Mechanisms and Recent Advancements in Chemo and Radio-resistance.Curr Gene Ther. 2017;16(6):375-389. doi: 10.2174/1566523217666170102105119. Curr Gene Ther. 2017. PMID: 28042781 Review.
-
Diverse functions of miR-373 in cancer.J Transl Med. 2015 May 20;13:162. doi: 10.1186/s12967-015-0523-z. J Transl Med. 2015. PMID: 25990556 Free PMC article. Review.
Cited by
-
MicroRNA-144 inhibits proliferation by targeting WW domain-containing transcription regulator protein 1 in papillary thyroid cancer.Oncol Lett. 2018 Jan;15(1):1007-1013. doi: 10.3892/ol.2017.7440. Epub 2017 Nov 17. Oncol Lett. 2018. PMID: 29399161 Free PMC article.
-
Identification of cancer-related miRNA-lncRNA biomarkers using a basic miRNA-lncRNA network.PLoS One. 2018 May 1;13(5):e0196681. doi: 10.1371/journal.pone.0196681. eCollection 2018. PLoS One. 2018. PMID: 29715309 Free PMC article.
-
Non-coding RNAs modulation in breast cancer radioresponse: mechanisms and therapeutic implications.Strahlenther Onkol. 2025 Jul;201(7):669-678. doi: 10.1007/s00066-024-02317-4. Epub 2024 Nov 15. Strahlenther Onkol. 2025. PMID: 39545960 Review.
-
P2Y2R-mediated inflammasome activation is involved in tumor progression in breast cancer cells and in radiotherapy-resistant breast cancer.Int J Oncol. 2018 Nov;53(5):1953-1966. doi: 10.3892/ijo.2018.4552. Epub 2018 Sep 4. Int J Oncol. 2018. PMID: 30226596 Free PMC article.
-
Radiation therapy for triple-negative breast cancer: emerging role of microRNAs as biomarkers and radiosensitivity modifiers. A systematic review.Breast Cancer Res Treat. 2022 Jun;193(2):265-279. doi: 10.1007/s10549-022-06533-3. Epub 2022 Apr 9. Breast Cancer Res Treat. 2022. PMID: 35397079
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous